IQVIA Holdings, US46266C1053

RBC raises target for IQVIA Holdings stock from USD 247 to USD 319

Published on 10/06/2026 at 10:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 4.37 billion in the second quarter of 2026, up 8.70 percent. IQVIA Holdings stock costs EUR 237.55 on October 6, 2026 after EUR 237.05.

Bauhaus-Poster mit PHARMA-Text geometrischen Formen und Primärfarben im Modernismus-Stil
IQVIA Holdings Sektor Pharmadienstleistungen US46266C1053 als Bauhaus Poster mit PHARMA Schriftzug in kräftigen Primärfarben, Illustration mit AI erstellt.

RBC Capital raised its price target for IQVIA Holdings stock from USD 247.00 to USD 319.00 on September 29, 2026, while maintaining an Outperform rating, according to Yahoo Finance. The target change gives the latest analyst view a clear numerical anchor as IQVIA prepares for its next quarterly report.

Second-quarter growth set the baseline

IQVIA reported second-quarter 2026 revenue of USD 4.37 billion, an 8.70 percent year-over-year increase, while adjusted earnings per share reached USD 3.15, up 12.10 percent from the comparable period, according to Zacks.

The operating picture also showed stronger commercial activity. Research and Development Solutions net new bookings rose 19.00 percent year over year to USD 3.20 billion in the second quarter of 2026, while operating cash flow increased 26.00 percent to USD 558.00 million.

Debt remains part of the valuation debate

IQVIA priced USD 2.00 billion of senior notes due 2034 on September 9, 2026, with a 6.375 percent coupon, according to the company's investor-relations release. The proceeds were designated to redeem the issuer's 5.000 percent notes due 2026, repay part of its revolving credit facility and cover transaction expenses.

That refinancing extends the maturity profile but carries a higher stated coupon than the debt being redeemed. For investors, the combination of 19.00 percent booking growth and the financing cost is the key contrast in the current IQVIA picture.

Results date gives the next checkpoint

IQVIA is scheduled to publish third-quarter 2026 results before the market opens on October 27, 2026, with a conference call at 9:00 a.m. ET, according to ScanX. That date puts the next test of revenue growth, bookings and cash generation ahead of the market's next reassessment of the USD 319.00 target.

IQVIA stock holds above its prior close

IQVIA stock was trading at EUR 237.55 at Lang & Schwarz on October 6, 2026 at 10:37 a.m. CEST, up 0.21 percent versus the EUR 237.05 prior close at Lang & Schwarz on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of IQVIA Holdings stock.

IQVIA Holdings market data

  • Company: IQVIA Holdings Inc.
  • ISIN: US46266C1053
  • WKN: A2JSPM
  • Ticker: IQV
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 6, 2026, 10:37 a.m. CEST: EUR 237.55
  • Change versus prior close: plus 0.21 percent
  • Prior close Lang & Schwarz October 5, 2026: EUR 237.05
  • Market capitalization: USD 43.8 billion as of October 5, 2026
  • 52-week range: USD 154.50-277.40 as of October 5, 2026
  • Sector / Industry: Healthcare / Diagnostics and Research
  • Next earnings date: October 27, 2026

More news and analyses on IQVIA Holdings stock

Disclaimer...

en | US46266C1053 | IQVIA HOLDINGS | boerse | 70240569 | bgmi